PURPOSE. Keratoconus (KTCN) is a noninflammatory thinning and anterior protrusion of the cornea that results in steepening and distortion of the cornea, altered refractive powers, and reduced visual acuity. Several loci responsible for a familial form of KTCN have been mapped, however; no mutations in any genes have been identified for any of these loci. There is also evidence that VSX1 and SOD1 may be involved in the etiology of KTCN. The purpose of this study was to verify the available data and to identify a new keratoconus susceptibility locus. METHODS. KTCN without other ocular or systemic features was diagnosed in 18 families. VSX1 and SOD1 sequencing was performed on affected individuals and control subjects. Genomewide linkage analysis was then performed in all families using polymorphic microsatellite markers with an average spacing of 5 cM. Next, single-nucleotide polymorphism (SNP) arrays, fluorescence in situ hybridization (FISH) analysis, and a comparative genomic hybridization array were used in one family to assess a candidate region on 13q32. RESULTS. All previously reported KTCN loci were excluded. VSX1 and SOD1 were sequenced, and no potentially functional variants were found. One KTCN family yielded a maximum multipoint parametric LOD score of 4.1 and multipoint nonparametric linkage (NPL) LOD score of 3.2. Multipoint linkage and haplotype analysis narrowed the locus to a 5.6-Mb region between the SNPs rs9516572 and rs3825523 on 13q32. CONCLUSIONS. The results exclude VSX1 and SOD1 as potential disease-causing genes in these families and localize a novel gene for keratoconus to a 5.6-Mb interval on 13q32. (Invest Ophthalmol Vis Sci.
K eratoconus (KTCN) is a noninflammatory thinning and consequent bulging of the cornea that results in distortion of the corneal surface, altered refractive powers of the eye (both axial and refractive), and reduced visual acuity. In more advanced cases, corneal scarring further reduces visual acuity. Symptoms are highly variable and depend on the stage of progression of the disorder.
1,2 The trait has an incidence of approximately 1 in 2000 individuals and is the most common indication for corneal transplantation in the United States. 1 Both, genetic and environmental factors are associated with KTCN. More than two dozen syndromes are associated with KTCN, including Down syndrome, 3 Leber's congenital amaurosis, 4 connective tissue disorders including osteogenesis imperfecta, 5 Gapo syndrome, 6 and some subtypes of Ehlers-Danlos syndrome. 7, 8 However, in most patients KTCN is an isolated ocular disorder and not a feature of a specific syndrome. Clinical studies have suggested that KTCN is associated with contact lens wear, chronic eye rubbing, and atopy of the eye. 1, 9, 10 Despite extensive study, the pathophysiological processes and the genetic etiology underlying KTCN have yet to be elucidated. Ninety percent of pedigrees with familial KTCN display an autosomal dominant inheritance with reduced penetrance. 11, 12 Six loci responsible for a familial form of KTCN have been mapped to 16q22.3-q23.1 (KTCN2; MIM [Mendelian Inheritance in Man] 608932), 3p14-q13 (KTCN3; MIM 608586), 2p24 (KTCN4; MIM 609271), 5q14.3-q21.1, 15q23-24, and 20q12. 11, [13] [14] [15] [16] [17] [18] However, to date, no mutations in any genes have been identified for any of these loci. There is also evidence that VSX1 on 20p11.2 (KTCN1; MIM 605,020) and SOD1 (MIM 147,450) on 21q22.11 are involved in the etiology of KTCN. 18, 19 We analyzed 18 Ecuadorian families with nonsyndromic KTCN. These families displayed an autosomal dominant inheritance pattern with reduced penetrance. No potentially functional variants were found in VSX1 and SOD1. Genome-wide linkage analysis provided significant evidence for a novel locus on 13q32 which maps to a 5.6-Mb genomic region.
METHODS

Clinical Evaluation of KTCN Families
Eighteen families from Ecuador with KTCN were ascertained and examined in the Hospital Metropolitano (Quito, Ecuador). All provided informed consent after the possible consequences of the study were explained, in accordance with the Declaration of Helsinki. All study subjects underwent a complete ophthalmic evaluation that included visual acuity (VA), IOP, biomicroscopic evaluation, and fundus examination with dilation. In addition, affected individuals and individuals with a suspected corneal abnormality underwent a topographic study (Humphrey Atlas Topograph; Carl Zeiss Meditec, Jena, Germany) with a computer-assisted videokeratoscope. Individuals with KTCN showed conical protrusion of the cornea, prominent corneal nerves, and corneal thinning with or without stromal scar tissue. The diagnosis of KTCN was established in subjects with at least two of the following topographic characteristics: (1) the curvature of the cornea more than 47 D (normal, ϳ43 D), (2) acentric or irregular corneal video keratography (CVK) shapes, and (3) inferior-superior (IS) value differences of 3 D, 3 mm below and above the center. We also examined all firstdegree relatives (parents, siblings, and grandparents) of affected individuals over the age of 11.
Pedigrees are shown in Figures 1 and 2 . Since the age of onset of KTCN is at puberty, 2 children younger than 16 years and unaffected were scored as "unknown phenotype status." Deceased individuals and individuals who did not wish to participate in the study were considered to have unknown affection status for the purpose of linkage analysis. Blood samples were collected from all participating family members after informed consent for the genetic studies was given.
Sequencing Analyses and Genome Wide Screen with Fluorescent Microsatellite Markers
Genomic DNA was prepared with a DNA extraction kit (Puregene; Qiagen, Inc., Valencia, CA). A total of 143 samples from 18 families were included in the analysis; 76 affected individuals, and 67 unaffected individuals. The coding regions and all splice junctions of VSX1 were sequenced before mapping studies in 57 affected individuals from all 18 families, in three unaffected individuals and in 20 unrelated Ecuadorian control subjects with no ocular abnormalities. SOD1 was also sequenced in two individuals with KTCN from each family (36 individuals). All exons of VSX1 and SOD1 as well as the intron-exon junctions were sequenced as described elsewhere. 19 PCR-based sequencing was performed with dye terminator chemistry (Big Dye Terminator Kit; Applied Biosystems, Inc.
[ABI], Foster City, CA) and visualized on a genetic analyzer (Prism 3100; ABI). The results were analyzed on computer (Sequencher software; Gene Codes Corp., Ann Arbor, MI).
Before the genomewide scan, targeted genotyping was performed with 120 polymorphic microsatellite markers that map to published candidate loci for familial KTCN on 16q22.3-q23.1, 3p14-q13, 2p24, 5q14.3-q21.1, 15q23-24, 20q12, 20p11.2 (VSX1), and 21q22 (SOD1). These 120 microsatellite markers consisted of 48 microsatellite markers (Prism Linkage Mapping Set, ver. 2.5; ABI) and 72 additional markers (Rutgers Combined Linkage-Physical Map, Build 36; http:// compgen.rutgers.edu/maps/ provided in the public domain by the department of Genetics, Rutgers University, Piscataway, NJ), 20 allowing for an average spacing of 1 to 1.5 cM across the published candidate loci for familial KTCN. Custom-designed fluorescence-labeled primers were obtained from Integrated DNA Technologies (Coralville, IA).
A genomewide screen was performed by genotyping the KTCN families with the remaining 763 fluorescently labeled PCR primer pairs (Prism Linkage Mapping Set, ver. 2.5; ABI) which are spaced approximately at 5 cM across the human genome. In both the targeted genotyping and genomewide screen, amplified products were visualized on a genetic analyzer (Prism 3100; ABI, equipped with 16 capillaries, a 36-cm array, POP-4 polymer, and GeneScan 400 HD [Rox] Size Standard). DNA amplifications of microsatellite markers were performed according to standard procedures in a total volume of 11 L with one of two PCR reagents (either True Allele PCR Premix or Master Mix AmpliTaq Gold reagent; ABI). The fragments were then sized on computer (PRISM GeneScan and Genotyper Software; ABI).
To reduce the candidate genomic region on 13q32, we selected polymorphic markers from the Rutgers Combined Linkage-Physical Map (Build 36) 20 to achieve a spacing of one microsatellite marker every 0.5 to 1.0 cM. Seventeen of these markers were informative and are shown in Table 1 .
Genome-wide Genotyping in Family KTCN-014
To further narrow the region of interest, a single-nucleotide-polymorphism (SNP) array (Affymetrix, GeneChip Mapping 250K Nsp Array) containing 262,000 SNPs was used to genotype 10 affected and 11 unaffected individuals from KTCN-014 (Fig. 2) .
These SNP markers are equally distributed in the genome with a median physical distance between SNPs of 4.8 kb, an average distance between SNPs of 11.2 kb, and an average heterozygosity of 0.30 (Affymetrix, Santa Clara, CA). The assay was performed with 250 ng of genomic DNA, and more than 99% of the SNPs were determined unequivocally for each sample. Scanned images were processed with gene microarray software (Affymetrix). The data were then analyzed on computer (GDAS ver. 2 software; GeneChip Data Analysis; Affymetrix).
Cytogenetic Analysis and Array Comparative Genomic Hybridization
To evaluate the possibility of copy number variation in the examined chromosome region fluorescence in situ hybridizations (FISH) was performed. Three affected (KTCN 14-06, 14-16, and 14-18) and two unaffected (KTCN 14 -02, 14-20) individuals were tested with eight fosmids (G248P82021F1, G248P8010G10, G248P87136A3, G248P8410H5, G248P86109F5, G248P88996E4, G248P86068C11, and G248P8720B7) and two BAC clones (RP11-123H22 [AL162717] and RP11-49K6 [AQ051918]) corresponding to 13q31-13q33. The probe assignment in the Human Mar 2006 (hg18; UCSC Genome Browser Web site, http:// genome.ucsc.edu/) assembly was confirmed by metaphase FISH, and then with interphase FISH with the probe combination performed as described elsewhere. 21 Two hundred interphase cells per slide were counted. Array comparative genomic hybridization (array CGH) was performed to assess the copy number differences at chromosome 13 in three affected (KTCN 14-03, 14-05, and 14-07) and two unaffected (KTCN 14-01, 14-14) individuals. Fine-tiling array CGH for chromosome 13 (human chromosome 13 CGH project) with ultra-high-density and long oligo probes (interval spacing: 221 bp [mean]; 225 bp [median]) was performed at NimbleGen Systems, Inc. (Reykjavik, Iceland).
Linkage Analysis
PEDCHECK
22 was used to identify Mendelian inconsistencies, and the MERLIN 23 program was used to detect double recombination events over short genetic distances that were probably due to genotyping errors. For the parametric linkage analysis an autosomal dominant mode of inheritance with reduced penetrance (0.8) and phenocopies (0.01) and a disease allele frequency of 0.0001 were used. In addition, for the parametric linkage analysis an affected only analysis was performed under an autosomal dominant mode of inheritance allowing for phenocopies. For the microsatellite marker, two-point parametric linkage analysis under homogeneity was performed with the MLINK program of the FASTLINK computer package, 24 and parametric linkage analysis allowing for linkage admixture was performed using HOMOG. 25 For microsatellite and SNP marker loci, multipoint nonparametric and parametric affected only linkage analysis under linkage homogeneity, and admixture was performed with ALLEGRO.
26
SIMWALK2
20,27 was used to perform parametric analysis with reduced penetrance, because of the large size of the pedigree. ALLEGRO 26 uses the Lander-Green algorithm, which limits the size of pedigree that can be analyzed in small-to medium-sized pedigrees. The microsatellite marker allele frequencies were estimated from the founders and reconstructed genotypes of founders from the 18 Ecuadorian pedigrees. Because the SNP markers were genotyped only in family 14, equal allele frequencies were used in the analysis. For both the microsatellite and SNP marker loci genetic map distances were then derived from the Rutgers combined linkage-physical map of the human genome, 20 either directly or by interpolation. Haplotypes were reconstructed using the SIMWALK2 program.
27,28
Web Resources
The URLs for data presented herein are as follows: Affymetrix, Santa Clara CA, http://www.affymetrix.com/products/arrays/specific/ 250k.affx/; Ensemble, 29 
RESULTS
Initial Candidate Gene Mutation Analyses
Before the genome-wide scan, the two known candidate genes VSX1 and SOD1 were excluded as causing KTCN in these families. Novel polymorphism 174GϾT (NM_014588), and p.P58P was identified in one affected individual and one control subject. There were three previously reported polymorphisms. Polymorphism c.18 GϾT (NM_014588), and p.S6S (rs8123716) was identified in five affected individuals and four 
Targeted Genotyping and Genome-Wide Screening
Targeted genotyping with polymorphic markers corresponding to published candidate genomic regions for familial KTCN on 20p11.2 (KTCN1, VSX1), 16q22.3-q23.1 (KTCN2), 3p14-q13 (KTCN3), 2p24 (KTCN4), 5q14.3-q21.1, 15q23-24, 20q12, and 21q22 (SOD1) revealed no evidence of linkage (LOD Ͻ 0.5) and did not produce parametric LOD scores Ͼ 0.5 between KTCN and these loci (data not shown).
The analysis of 17 of 18 KTCN families did not reveal evidence of linkage (LOD scores Ͻ 0.5), both for parametric and nonparametric linkage analysis under linkage homogeneity and allowing for linkage admixture.
In family KTCN-014, a maximum two-point parametric LOD score of 4.1 was obtained for the reduced penetrance analysis and a LOD score of 3.2 for the affected only analysis; both LOD scores occurred at marker D13S159 ( ϭ 0.0). Table 1 displays parametric two-point LOD scores for the reduced penetrance model for all microsatellites within the linkage region on chromosome 13. Genotyping data from a 250 k Nsp array (Affymetrix) in family KTCN-014 revealed similar multipoint parametric LOD and NPL LOD scores. A maximum multipoint LOD score of 4.12 was observed at markers rs9561930ϳrs7339158, and rs774693ϳrs17473024 (Table 2 ) and reduced the genetic interval from a 12.0-Mb to a 5.59-Mb region between SNPs rs9516572 to rs3825523 on 13q32. Genotypes and haplotypes of 13q32 for family KTCN-014 are presented in Figure 2 . The relationship of the pedigree members was confirmed by analyzing Ͼ5000 marker loci using the GRR program. 30 This program evaluates relationship of individuals by evaluating the proportion of alleles that are identical by state. We confirmed that the relationship of all pedigree members is consistent with the pedigree structure and that the four founders are unrelated to one other. Figure 3 summarizes the full results of the genomewide scan for family KTCN-014 and shows a multipoint NPL LOD score of 3.2 obtained in this region. Haplotype analysis identified the risk haplotype shared by all affected individuals, one unaffected (KTCN 14-13) and one individual with unknown status (KTCN 14-21) . Ocular examination performed for individual 14-13 at age 53 did not reveal KTCN. Since KTCN demonstrates reduced penetrance, we speculate that this individual with normal phenotype at age of 53 and an "at risk" haplotype is nonpenetrant for the KTCN phenotype. Individual 14-21 was 14 at the time of examination, presented with no KTCN and the "unknown" status was assigned in accordance with the criteria applied to all families. We speculate that this individual with normal phenotype and "at risk" genotype may develop KTCN when older.
Cytogenetic analysis and array CGH did not show any copy number variations on 13q32.
DISCUSSION
We report a novel KTCN locus on 13q32. Several loci have been identified for KTCN. 11, [13] [14] [15] [16] [17] [18] A locus for autosomal dominant KTCN was mapped in Finnish families 16 on 16q22.3-q23.1. 16 Another locus on 15q22.33-24.2 was reported in a three-generation Northern Irish family whose affected individ- 
uals presented with combined early-onset autosomal dominant anterior polar cataract and KTCN and candidate genes CTSH, CRABP1, IREB2, and RAS-GRF1 were excluded. 11 Other combined disease phenotypes were mapped to 17p13 in a twogeneration Pakistani family with autosomal recessive Leber congenital amaurosis and KTCN. 31 A locus on chromosome 3 was mapped to 3p14-q13 in a two-generational Italian family with autosomal dominant KTCN.
14 Mutation analysis of COL8A1, the candidate gene located within the genetic region, did not show any pathogenic mutation.
14 An additional locus for KTCN was identified using the genomewide scan approach on 5q14.3-q21.1 in a four-generation autosomal dominant white pedigree. 15 A locus on 2p24 was identified in a heterogeneous population of 28 families recruited in France, Spain, and Guadeloupe, of European, Arab, and Caribbean-African descent. 13 Mutations in two genes have been evaluated as the cause of disease etiology. Mutations in the VSX1 homeobox gene (locus on 20p11.21, KTCN1) were reported to cause posterior polymorphous dystrophy (PPD) and KTCN 18 and recently, in another study, a heterozygous genomic 7-bp deletion in intron 2 of a SOD1 gene was identified in two pedigrees with three affected patients with KTCN. 19 Aldave et al. 32 performed direct sequencing of the VSX1 gene in 100 unrelated patients with KTCN; of the four mutations in the VSX1 gene, only one was identified in a single affected patient. We detected no causative mutation in VSX1. In our study, several SNPs were identified, but those that were identified in affected individuals were also found in unaffected relatives and in normal ethnically matched individuals. These data suggest that the genetic cause(s) of KTCN in these families is (are) not due to mutations in the coding region of VSX1. It is possible that intronic mutations or mutations that affect the promoter region of VSX1 could be present and not detected by our mutation analysis. For this reason, a linkage study with markers that map to chromosome 20 was performed and showed no evidence for linkage between KTCN and the microsatellite markers at that locus (data not shown). These findings exclude this locus as a candidate for KTCN in this population. A similar approach was followed for SOD1, in which a heterozygous genomic 7-bp deletion in intron 2 was identified in three individuals with KTCN. 19 No causative mutations were detected in SOD1 in these Ecuadorian families. Genotyping with microsatellite markers from chromosome 21, region q22 excluded SOD1 as a candidate for KTCN in this population.
Our results suggest that the KTCN gene in the cohort from Ecuador does not map to any previously described candidate locus. Only family KTCN-014 displayed linkage to 13q32. Although we tried to minimize the genetic heterogeneity by studying families from a single population, these results are not surprising, since KTCN is genetically heterogeneous with many previously reported loci.
Although no linkage studies have previously implicated this region in familial KTCN, it is interesting to note that a sporadic case of KTCN was observed to have a chromosomal abnormality involving a 13q ring abnormality designated as 46,XX,r(13)(p11q34).ish r(13) (p11q34)(85A10Ϫ). 33 The 19-year-old female patient had no atopy and no family history of ocular problems. The 13q32 region is a known locus for neocentromere formation, 34 resulting in chromosomal imbalances: Tetrasomy of 13q32-qter has been observed, with eye abnormalities including agenesis, microphthalmia, iris, and choroidal colobomata. 35 These findings could be consistent with the presence of a dosage-sensitive locus on 13q that causes ocular anomalies. Since array CGH is an effective tool for analyzing copy number variation, 36 this and other cytogenetic analyses were performed to verify this hypothesis in several individuals from family KTCN-014. Our analyses did not reveal any copy number variation on 13p32 in the tested individuals. However, although we applied an ultra-high-density array, it is possible that small deletion or duplications were missed.
The 5.6-Mb locus we identified on 13q32 contains 23 known transcripts (Ensembl). 29 Candidate genes include muscleblind In summary, the present study provides evidence of KTCN susceptibility loci on 13q32. Further studies are needed to delineate the role of other potential loci involved in KTCN in the families of different geographic origins. 
